Advertisement
| delix therapeutics stock: Charney and Nestler's Neurobiology of Mental Illness Dennis Charney, Eric Nestler, Joseph D. Buxbaum, Elisabeth B. Binder, Joshua A. Gordon, Marina R. Picciotto, 2025-01-03 The genetic investigation into mental illnesses has progressed rapidly since the mapping of the human genome. Driven by advances in genomic profiling technology, massive genomic datasets are powering the discovery of genetic variation associated to complex traits including mental illness. From severe neurodevelopmental disorders to schizophrenia and depression, genetic variation plays some role in risk. Critically, most mental illnesses are complex, multifactorial and the consequence of a combination of genetic and environmental influences. This chapter will introduce the genome, its variation, and the methods used to identify what variants and genes matter for mental illnesses-- |
| delix therapeutics stock: Anxiety and Depression Association of America Patient Guide to Mood and Anxiety Disorders Charles B. Nemeroff, M.D., Ph.D., W. Edward Craighead, Ph.D., 2024-04-15 |
| delix therapeutics stock: Rapid Acting Antidepressants , 2020-06-26 The Advances in Pharmacology series presents a variety of chapters from the best authors in the field. |
| delix therapeutics stock: Cash Flow Hedge Accounting of Forecast Intragroup Transactions , 2004 |
| delix therapeutics stock: Hereditary Kidney Diseases A. Sessa, F. Conte, M. Meroni, G. Battini, Claudio Ronco, 1997 I would recommend this slim volume for geneticists with an interest in hereditary kidney diseases who would appreciate well written and referenced, up to date papers on the specific conditions included.' Journal of Medical Genetics |
| delix therapeutics stock: Clinical Practice Guidelines We Can Trust Institute of Medicine, Board on Health Care Services, Committee on Standards for Developing Trustworthy Clinical Practice Guidelines, 2011-06-16 Advances in medical, biomedical and health services research have reduced the level of uncertainty in clinical practice. Clinical practice guidelines (CPGs) complement this progress by establishing standards of care backed by strong scientific evidence. CPGs are statements that include recommendations intended to optimize patient care. These statements are informed by a systematic review of evidence and an assessment of the benefits and costs of alternative care options. Clinical Practice Guidelines We Can Trust examines the current state of clinical practice guidelines and how they can be improved to enhance healthcare quality and patient outcomes. Clinical practice guidelines now are ubiquitous in our healthcare system. The Guidelines International Network (GIN) database currently lists more than 3,700 guidelines from 39 countries. Developing guidelines presents a number of challenges including lack of transparent methodological practices, difficulty reconciling conflicting guidelines, and conflicts of interest. Clinical Practice Guidelines We Can Trust explores questions surrounding the quality of CPG development processes and the establishment of standards. It proposes eight standards for developing trustworthy clinical practice guidelines emphasizing transparency; management of conflict of interest ; systematic review-guideline development intersection; establishing evidence foundations for and rating strength of guideline recommendations; articulation of recommendations; external review; and updating. Clinical Practice Guidelines We Can Trust shows how clinical practice guidelines can enhance clinician and patient decision-making by translating complex scientific research findings into recommendations for clinical practice that are relevant to the individual patient encounter, instead of implementing a one size fits all approach to patient care. This book contains information directly related to the work of the Agency for Healthcare Research and Quality (AHRQ), as well as various Congressional staff and policymakers. It is a vital resource for medical specialty societies, disease advocacy groups, health professionals, private and international organizations that develop or use clinical practice guidelines, consumers, clinicians, and payers. |
| delix therapeutics stock: Pumps, Channels and Transporters Ronald J. Clarke, Mohammed A. A. Khalid, 2015-09-16 Describes experimental methods for investigating the function of pumps, channels and transporters Covers new emerging analytical methods used to study ion transport membrane proteins such as single-molecule spectroscopy Details a wide range of electrophysiological techniques and spectroscopic methods used to analyze the function of ion channels, ion pumps and transporters Covers state-of-the art analytical methods to study ion pumps, channels, and transporters, and where analytical chemistry can make further contributions |
| delix therapeutics stock: Biotechnology Guide U.S.A. Mark D. Dibner, 1997 |
| delix therapeutics stock: Trauma- and Stressor-Related Disorders Frederick J. Stoddard Jr., David M. Benedek, Mohammed R. Milad, Robert J. Ursano, 2018-05-04 Trauma, stress, and manmade and natural disasters are increasingly impacting individuals and communities. The clinical and scientific advances presented here strive to address the rapidly expanding individual and community burden of disease resulting from the experience of traumatic or stressful events. The authors describe the suffering which trauma- and stressor-related disorders (TSRDs) cause, and explain in 30 concise chapters the state of the science for the DSM-5 trauma- and stressor-related disorders with regard to pathogenesis, diagnostic assessment and approach to treatment. This volume presents the genetic, neurochemical, developmental, and psychological foundations and epidemiology of the trauma- and stressor-related disorders, in addition to specific guidance on screening and evaluation, diagnosis, prevention, and biological, psychological and social treatments. The chapters in this book cover a variety of TSRDs: posttraumatic stress disorder, acute stress disorder, adjustment disorders, persistent complex bereavement disorder, and reactive attachment and disinhibited social engagement disordersd. Graphics, including neuroimaging are integrated for easy reference and to aid grasping of key concepts. The book draws on the current literature and provides brief case scenarios from individuals and families exposed to psychological or physical traumas, including mass trauma events. Factors contributing to susceptibility to these disorders and to resilience are also addressed. Trauma- and Stressor-Related Disorders provides an in-depth yet succinct introduction to current clinical and research knowledge for trainees and for professionals including psychotherapeutic, psychopharmacological, public health, and policy interventions. It addresses the level of evidence for different best practices to target the disabling cognitive, emotional or behavioral symptoms for a specific patient or population. |
| delix therapeutics stock: Microdosing Psychedelics Paul Austin, 2018-06-27 Microdosing Psychedelics: A Practical Guide to Upgrade Your Life by Paul Austin is a comprehensive guide to all the necessary information on the practice of microdosing - including protocols, benefits, drawbacks, and sourcing. Weaving together anecdotal narratives and preliminary research on the use of small amounts of psychedelics, Microdosing Psychedelics is oriented toward anyone interested in microdosing to improve their general well-being, particularly those in leadership and creative positions.Over the last few years, microdosing has entered the cultural zeitgeist. From bio-hackers in Silicon Valley seeking to improve their focus, to writers and artists looking for a creative edge, to suburban moms struggling with depression, to everyday people who want to achieve emotional balance, microdosing has led the way in mainstreaming and normalizing psychedelics. In the most comprehensive book of its kind, author, public speaker, and microdosing expert Paul Austin provides a thorough overview of how just about anyone can benefit from an intentional, structured microdosing protocol. In Microdosing Psychedelics, Austin provides readers with everything they need to know about microdosing, including:*What exactly is microdosing and how did it become a thing?*How to set up a weekly schedule if you want to experiment with microdosing*Three ways microdosing can benefit your professional career*The safest and easiest ways to obtain psychedelics if you wish to experiment with microdosing |
| delix therapeutics stock: Weekends at Bellevue Julie Holland, 2009 Documents a psychiatrist's employment at New York City's Bellevue Hospital while sharing the life lessons she learned from her patients and colleagues, describing some of the more remarkable cases of her career, her friendship with a cancer-stricken mentor, and their influences on her family life. |
| delix therapeutics stock: Evidence-Based Medicine Guidelines Duodecim Medical Publications, 2005-03-04 Evidence-Based Medicine Guidelines fills the demand for a handbook discussing the diagnosis and treatment of a wide range of diseases and conditions encountered by health care professionals. The title was first published in Finland by the Finnish Medical Society, where it is now considered to be the single most important support tool for the physicians' decision making in their daily work. What sets EBM Guidelines apart from competing books? Provides physicians with fast and easy access to practice guidelines based on the best available research evidence Covers practically all medical conditions encountered in general practice Developed by over 300 experienced general practitioners and specialists worldwide Includes both diagnostic and therapeutic guidelines, and recommendations on diagnostic tests and drug dosage Presented in a user-friendly format with self contained chapters based on clinical subjects Clear and concise explanations of all available evidence results in the guideline for treatment The strength of evidence is graded from A-D making this title a quick and easy reference whenever and wherever you need it! Assumes no prior knowledge of EBM or statistics - all the work of searching and appraisal has been done for you! Seeks to include guidelines where clinical evidence is incomplete or unavailable Contains full-colour photographs and tables throughout Easy-to-read and fast support at the point of care - EBM Guidelines: Summarises the best available evidence - Cochrane reviews - DARE abstracts - Clinical Evidence topics - original articles in medical journals - abstracts in the Health Technology Assessment Database - NHS Economic Evaluation Evaluates and grades the strength of all individual evidence from A (Strong research-based evidence) to D (No scientific evidence) Suggests guidelines based on clinical evidence. If clinical evidence is inadequate or missing, an expert panel evaluate all other available information and suggests the appropriate guideline With over 1000 problem-orientated or disease-specific guidelines including reference to evidence summaries for all guidelines, this title is the most extensive collection of guidelines for primary care today. Here are just a few examples of the raving reviews for Evidence-Based Medicine Guidelines: An excellent resource... quick to use, even during consultations...very helpful to check whether our preferred diagnostic and therapeutic methods are adequate...competent suggestions based on real evidence... —Heinz Bhend, PRIMARY CARE clinically useful answers...easy-to-read ...this resource is worth using... —Carl Heneghan, Centre for Evidence-Based Medicine, Oxford, UK, EVIDENCE-BASED MEDICINE Journal |
| delix therapeutics stock: Retraumatization Melanie P. Duckworth, Victoria M. Follette, 2012-05-22 Exposure to potentially traumatic events puts individuals at risk for developing a variety of psychological disorders; the complexities involved in treating them are numerous and have serious repercussions. How should diagnostic criteria be defined? How can we help a client who does not present with traditional PTSD symptoms? The mechanisms of human behavior need to be understood and treatment needs to be tested before we can move beyond traditional diagnostic criteria in designing and implementing treatment. No better guide than Retraumatization exists to fulfill these goals. The editors and contributors, all highly regarded experts, accomplish six objectives, to: define retraumatization outline the controversies related to it provide an overview of theoretical models present data related to the frequency of occurrence of different forms of trauma detail the most reliable strategies for assessment to provide an overview of treatments. Contained within is the most current information on prevention and treatment approaches for specific populations. All chapters are uniformly structured and address epidemiological data, clinical descriptions, assessment, diagnosis and prognosis, and prevention. It is an indispensible resource that expands readers’ knowledge and skills, and will encourage dialogue in a field that has many unanswered questions. |
| delix therapeutics stock: The Violence of Men Cloé Madanes, James P. Keim, Dinah Smelser, 1995-08-09 Offers a method of curing the supposedly incurable: men who physically and sexually abuse their wives and children. The author provides a step-by-step programme for rehabilitation and reunification of the family based on personal responsibility, repentance |
| delix therapeutics stock: Tackling Trauma Paul A. Barker, 2019-03-14 Trauma is a universal phenomenon that can be caused by international catastrophes or individual, personal tragedy. Trauma is also a severely neglected topic in Christian literature, and while it can challenge someone’s faith in Christ, God and the ministry of his Word is central to dealing with the emotional and psychological impact of trauma. By his Spirit, through his Word, and through his church, God is available to minister to people suffering from trauma and bring transformation to their lives. In this book, a team of experienced and informed Christian professionals from around the world promote a deep biblical response to trauma through clinical and theological wisdom and their first-hand experience of witnessing and experiencing trauma. The contributions provide practical responses to people’s trauma, rather than mere descriptions of the problems, making it an ideal resource for pastors, counsellors, humanitarian workers and students. |
| delix therapeutics stock: Nitrogen in Agriculture Takuji Ohyama, Kazuyuki Inubushi, 2021-09-29 Nitrogen is the most important nutrient in agricultural practice because the availability of nitrogen from the soil is generally not enough to support crop yields. To maintain soil fertility, the application of organic matters and crop rotation have been practiced. Farmers can use convenient chemical nitrogen fertilizers to obtain high crop yields. However, the inappropriate use of nitrogen fertilizers causes environmental problems such as nitrate leaching, contamination in groundwater, and the emission of N2O gas. This book is divided into the following four sections: “Ecology and Environmental Aspects of Nitrogen in Agriculture”, “Nitrogen Fertilizers and Nitrogen Management in Agriculture”, “N Utilization and Metabolism in Crops”, “Plant-Microbe Interactions”. |
| delix therapeutics stock: Handbook of Lipids in Human Nutrition Gene A. Spiller, 2020-08-11 The Handbook of Lipids in Human Nutrition is a concise reference for professionals and students interested in the role of lipids in nutrition. Over 100 tables and illustrations provide quick access to the most current data available. |
| delix therapeutics stock: Alan Yu, Director for Asian Affairs at U.S. Department of Energy Ronald Russell, Alex Medvedev, 2016-10-05 Biography of Alan Yu, currently Director for Asian Affairs at U.S. Department of Energy, previously Director for Policy and Public Outreach at Bureau of Oceans and International Environmental and Scientific Affairs and U.S. National Contact Point - Corporate Social Responsibility at Bureau of Economic and Business Affairs, U.S. Department of State. |
| delix therapeutics stock: Treatment of Complex Trauma Christine A. Courtois, Julian D. Ford, 2012-10-22 This insightful guide provides a pragmatic roadmap for treating adult survivors of complex psychological trauma. Christine Courtois and Julian Ford present their effective, research-based approach for helping clients move through three clearly defined phases of posttraumatic recovery. Two detailed case examples run throughout the book, illustrating how to plan and implement strengths-based interventions that use a secure therapeutic alliance as a catalyst for change. Essential topics include managing crises, treating severe affect dysregulation and dissociation, and therapist self-care. The companion website offers downloadable reflection questions for clinicians and extensive listings of professional and self-help resources. A new preface in the paperback and e-book editions addresses key scientific advances. See also Drs. Courtois and Ford's edited volumes, Treating Complex Traumatic Stress Disorders in Adults, Second Edition, and Treating Complex Traumatic Stress Disorders in Children and Adolescents, which present research on the nature of complex trauma and review evidence-based treatment models. Winner (Second Place)--American Journal of Nursing Book of the Year Award, Psychiatric and Mental Health Nursing Category |
| delix therapeutics stock: Therapeutic Monthly , 1902 |
| delix therapeutics stock: Reports to the Malaria Committee of the Royal Society Royal Society (Great Britain). Malaria Committee, 1900 |
| delix therapeutics stock: Michigan Medical News John Jolliffe Mulheron, 1878 |
| delix therapeutics stock: Transactions of the Section on Gynecology of the College of Physicians of Philadelphia College of Physicians of Philadelphia. Section on Gynecology, 1897 |
| delix therapeutics stock: American Cicero Bradley J. Birzer, 2023-06-20 Aristocrat. Catholic. Patriot. Founder. Before his death in 1832, Charles Carroll of Carrollton—the last living signer of the Declaration of Independence—was widely regarded as one of the most important Founders. Today, Carroll's signal contributions to the American Founding are overlooked, but the fascinating new biography American Cicero rescues Carroll from unjust neglect. Drawing on his considerable study of Carroll's published and unpublished writings, historian Bradley J. Birzer masterfully captures a man of supreme intellect, imagination, integrity, and accomplishment. Born a bastard, Carroll nonetheless became the best educated (and wealthiest) Founder. The Marylander's insight, Birzer shows, allowed him to recognize the necessity of independence from Great Britain well before most other Founders. Indeed, Carroll's analysis of the situation in the colonies in the run-up to the Revolution was original and brilliant—yet almost all historians have ignored it. Reflecting his classical and liberal education, the man who would be called The Last of the Romans advocated a proper understanding of the American Revolution as deeply rooted in the Western tradition. Carroll even left his mark on the U.S. Constitution despite not assuming his elected position to the Constitutional Convention: by inspiring the creation of the U.S. Senate. American Cicero ably demonstrates how Carroll's Catholicism was integral to his thought. Oppressed because of his faith—Maryland was the most anti-Catholic of the original thirteen colonies—Carroll became the only Roman Catholic to sign the Declaration of Independence and helped legitimize Catholicism in the young American republic. What's more, Birzer brilliantly reassesses the most controversial aspects of Charles Carroll: his aristocratic position and his critiques of democracy. As Birzer shows, Carroll's fears of extreme democracy had ancient and noble roots, and his arguments about the dangers of democracy influenced Alexis de Tocqueville's magisterial work Democracy in America. American Cicero reveals why Founders such as John Adams assumed that Charles Carroll would one day be considered among the greats—and also why history has largely forgotten him. |
| delix therapeutics stock: Progressive Medicine Hobart Amory Hare, 1899 A quarterly digest of advances, discoveries, and improvements in the medical and surgical sciences. |
| delix therapeutics stock: Transactions of the Association of American Medical Colleges Association of American Medical Colleges, 1898 |
| delix therapeutics stock: The Lake and Brook Lampreys of New York Simon Henry Gage, 1893 |
| delix therapeutics stock: Detroit Medical Journal , 1916 |
| delix therapeutics stock: The Two Marys Sylvia Browne, Lindsay Harrison, 2007-11-06 The #1 New York Times bestselling author addresses the controversial questions about the life of Jesus Christ and the women in his life. An extraordinary message from ?possibly the most famous psychic in the world,?(Mystic Living Today)Sylvia Browne: ?In writing this book, I was amazed to find out that I actually had visions of what was happening...a manifestation of the infusion that I was getting from God. God does work in mysterious ways.? Many controversies have gone unanswered in Christianity for centuries. Now, told from the unique perspective only Sylvia Browne could bring, The Two Marys focuses on the greatest of those extraordinary unknowns: the two most important women in Jesus?s life?his mother and his wife?whose profound influence on him has been marginalized by Christian churches and reinvented out of contradictions, misrepresentations, and fabrications. Finally, Sylvia Browne uncovers the hidden history of these two remarkable women in a story that will challenge the very basis of traditional Christian faith. |
| delix therapeutics stock: University Medical Magazine , 1889 |
| delix therapeutics stock: Dental Materia Medica , 1868 |
| delix therapeutics stock: St. Louis Medical Gazette , 1898 |
| delix therapeutics stock: Technology Today Edward De Bono, 1971 |
| delix therapeutics stock: Dental Materia Medica Prosper H. Marsden, 1926 |
Transforming the Treatment of Brain Health - Delix Therapeutics
Delix is harnessing the power of a novel class of compounds known as neuroplastogens, to bring about a new paradigm in brain health therapeutics: treatments intended to be safe, fast acting, …
Delix in the News - Delix Therapeutics
Find the latest news articles, media, and press releases about Delix Therapeutics’ scientific, clinical, technological, and corporate accomplishments
Delix Pipeline of Psychoplastogens and Neuroplastogens - Delix …
Discover more about Delix’s assets in development for brain health disorders such as neuropsychiatric, affective, psychosis & neurodegenerative disorders
Delix Plans Further Trials With Neuroplastogen After Positive …
Delix Therapeutics is planning to initiate two studies to evaluate patients with major depression investigating its lead neuroplastogen candidate, DLX-001, Delix CMO Dr. Aaron Koenig told …
Our Team Pushing the Boundaries of Neuroscience - Delix …
The Delix team has one mission—to provide novel therapeutic options for brain disorders. We share a passion for using revolutionary science to help patients who have not been served …
Delix Therapeutics Announces Completion of 1st Cohort Dosing, …
Jun 20, 2023 · Delix is rapidly advancing these compounds through preclinical and clinical development to bring patients FDA-approved, take-home medicines that will serve several …
Delix Presents Interim Data From Phase I Trial of Novel …
Through its novel Neuroplastogen Platform, Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and rapidly advancing through preclinical and clinical …
Delix Presents Full Results from Phase 1 Trial of DLX-001 at ACNP ...
In addition to this Phase 1 data, Delix presented preclinical findings on its newest neuroplastogen developmental candidate, DLX-159, an orally bioavailable, non-hallucinogenic small molecule …
Invest In Future Brain Health, Next-Gen Neurological Treatments
Delix is revolutionizing the future of neurological therapies by redefining treatment approaches and advancing innovative solutions that promise to transform patient care.
Delix Therapeutics Announces Dosing of First Patient in Phase 1b ...
Through its novel Neuroplastogen Platform, Delix is pioneering a new class of fast-acting outpatient pharmacotherapies and rapidly advancing through preclinical and clinical …
